J. Randolph Hecht MD

Gastrointestinal Cancer

Professor of Clinical Medicine; Director UCLA GI Oncology Program

2020 Santa Monica Blvd. #600Santa Monica, CA 90404
Phone+1 310-829-5471
Fax+1 310-829-6192

Dr. Hecht is on Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Hecht's full profile Already have an account?

Education & Training

UCLA David Geffen School of Medicine/UCLA Medical CenterFellowship, Hematology and Medical Oncology, 1995 - 1997
UCLA David Geffen School of Medicine/UCLA Medical CenterFellowship, Gastroenterology, 1988 - 1991
University of ChicagoFellowship, Research, 1987 - 1988
McGaw Medical Center of Northwestern UniversityResidency, Internal Medicine, 1984 - 1987
Eastern Virginia Medical SchoolClass of 1984

The following disclaimer is related to board certifications obtained from ABMS®, denoted by the ABMS® logo.

This information is proprietary data maintained in a copyrighted database owned by the American Board of Medical Specialties®. The display and presence of ABMS Data in no way constitutes any affiliation, association with, or endorsement of any advertising, promotion, or sponsorship by ABMS and its affiliates and subsidiaries, the ABMS Member Boards, or ABMS board certified physicians and medical specialists. Copyright 2026 American Board of Medical Specialties®. All rights reserved.

The user is responsible for ensuring that the profile obtained in this directory is the profile of the physician or medical specialist being sought.

A self-designated specialty, subspecialty, or practice area neither implies nor is equivalent to ABMS board certification or the existence of specialized training by or competence of a physician or medical specialist.

Certifications & Licensure

CA State Medical License 1988 - 2027
IL State Medical License 1986 - 1990
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2014, 2016-2017
CMS Meaningful Use Stage 2 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2014, 2016-2017
Super Doctor SuperDoctors.com

Clinical Trials

A Study of PF-08046052/SGN-EGFRd2 in Advanced Solid Tumors Start of enrollment: 2023 Nov 14
TERMINATED
PHASE1
Roles: Contact, Principal Investigator

Publications & Presentations

PubMed

5 citations
Phase Ib/II trial of talimogene laherparepvec alone and with pembrolizumab in advanced solid tumors with liver metastases and hepatocellular carcinoma.
Joel Randolph Hecht, Arjun Oberoi, Elena Garralda Cabanas, Hong Jae Chon, Antonia Digklia
The Oncologist. 2025-03-10
260 citations
Erlotinib Plus Gemcitabine Compared With Gemcitabine Alone in Patients With Advanced Pancreatic Cancer: A Phase III Trial of the National Cancer Institute of Canada Cl...
Malcolm J Moore, David Goldstein, John Hamm, Arie Figer, Joel R Hecht
Journal of Clinical Oncology. 2023-10-20
13 citations
Fecal and Tissue Microbiota Are Associated with Tumor T-Cell Infiltration and Mesenteric Lymph Node Involvement in Colorectal Cancer.
Kayti Luu, Jason Y Ye, Venu Lagishetty, Fengting Liang, Megan Hauer
Nutrients. 2023-01-09

Lectures

A phase 1b/2, multicenter, open-label trial to evaluate the safety of talimogene laherparepvec (T-VEC) injected into primary and metastatic liver tumors alone and in c...
2018 ASCO Annual Meeting - Chicago, Illinois - 06/4/2018
Overall survival of PEGylated pegilodecakin with 5-FU/LV and oxaliplatin (FOLFOX) in metastatic pancreatic adenocarcinoma (PDAC).
2018 ASCO Annual Meeting - Chicago, Illinois - 06/3/2018